MedTrace Logo

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis

NCT05660694 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-12-21

No results posted yet for this study

Summary

To compare the efficacy of Triamcinolone with Pentoxifylline and Vitamin E in patients with stage two and three oral submucous fibrosis.

Conditions

  • Triamcinolone
  • Pentoxifylline
  • Vitamin E
  • Oral Submucosa Fibrosis
  • Tumor

Interventions

DRUG

Triamcinolone

Comparison of Triamcinolone with Pentoxifylline and Vitamin- E Efficacy

DRUG

Pentoxifylline with Vitamin E

Comparison of Triamcinolone with Pentoxifylline and Vitamin- E Efficacy

Sponsors & Collaborators

  • Altamash Institute of Dental Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05660694 on ClinicalTrials.gov